Continuing Struggle Shows TASER Device Not the Cause of DeathSCOTTSDALE, Ariz., Nov 16, 2007 (PrimeNewswire via COMTEX News Network) -- TASER International, Inc. (Nasdaq:TASR), a market leader in advanced electronic control devices, released the following statement regarding the mid-October confrontation between Mr. Robert Dziekanski and the Royal Canadian Mounted Police at the Vancouver airport. An amateur video of the incident that was released earlier this week has received sensational coverage from the media with many reports drawing an unsubstantiated and uninformed conclusion as to the cause of Mr. Dziekanski's death.
"This tragic incident appears to follow the pattern of many in-custody deaths or deaths following a confrontation with police. Historically, medical science and forensic analysis has shown that these deaths are attributable to other factors and not the low-energy electrical discharge of the TASER(r). Specifically in Canada, while previous incidents were widely reported in the media as 'TASER deaths,' the role of the TASER device has been cleared in every case to date -- including the widely publicized Bagnell in-custody death in Vancouver where the TASER device was cleared by an inquest jury."
"Cardiac arrest caused by electrical current is immediate. The video of the incident at the Vancouver airport indicates that the subject was continuing to fight well after the TASER application. This continuing struggle could not be possible if the subject died as a result of the TASER device electrical current causing cardiac arrest. His continuing struggle is proof that the TASER device was not the cause of his death. Further, the video clearly shows symptoms of excited delirium, a potentially fatal condition marked by symptoms of exhaustion and mania such as heavy breathing, profuse sweating, confusion, disorientation and violence toward inanimate objects."
"We are taken aback by the number of media outlets that have irresponsibly published conclusive headlines blaming the TASER device and / or the law enforcement officers involved as the cause of death before completion of the investigation. These sensationalistic media reports completely ignore the earmark symptoms of excited delirium shown in the video. TASER International is transmitting over 60 legal demand letters requiring correction of these false and misleading headlines and will take other actions as appropriate. These unsubstantiated, false headlines mislead the public and could adversely influence public policy in ways which could place the lives of both law enforcement and the public at greater risk," concluded Tom Smith, Founder and Chairman of the Board of TASER International, Inc.
About TASER International, Inc.
TASER International's products protect life. TASER provides advanced Electronic Control Devices (ECDs) for use in the law enforcement, medical, military, corrections, professional security, and personal protection markets. TASER devices use proprietary technology to incapacitate dangerous, combative, or high-risk subjects who pose a risk to law enforcement officers, innocent citizens, or themselves in a manner that is generally recognized as a safer alternative to other uses of force. For more information please call TASER International at (800) 978-2737 or visit our website at www.TASER.com.
The TASER International logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=2931
Note to Investors
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements, without limitation, regarding our expectations, beliefs, intentions or strategies regarding the future. We intend that such forward-looking statements be subject to the safe-harbor provided by the Private Securities Litigation Reform Act of 1995. The forward-looking information is based upon current information and expectations regarding TASER International. These estimates and statements speak only as of the date on which they are made, are not guarantees of future performance, and involve certain risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results could materially differ from what is expressed, implied, or forecasted in such forward-looking statements.
TASER International assumes no obligation to update the information contained in this press release. These statements are qualified by important factors that could cause our actual results to differ materially from those reflected by the forward-looking statements. Such factors include but are not limited to: (1) market acceptance of our products; (2) our ability to establish and expand direct and indirect distribution channels; (3) our ability to attract and retain the endorsement of key opinion-leaders in the law enforcement community; (4) the level of product technology and price competition for our products; (5) the degree and rate of growth of the markets in which we compete and the accompanying demand for our products; (6) risks associated with rapid technological change and new product introductions; (7) competition; (8) litigation including lawsuits resulting from alleged product related injuries and death; (9) media publicity concerning allegations of deaths and injuries occurring after use of the TASER device and the negative effect this publicity could have on our sales; (10) TASER device tests and reports; (11) product quality; (12) implementation of manufacturing automation; (13) potential fluctuations in our quarterly operating results; (14) financial and budgetary constraints of prospects and customers; (15) order delays; (16) dependence upon sole and limited source suppliers; (17) negative reports concerning the TASER device; (18) fluctuations in component pricing; (19) government regulations and inquiries; (20) dependence upon key employees and our ability to retain employees; (21) execution and implementation risks of new technology; (22) ramping manufacturing production to meet demand; (23) medical and safety studies; (24) field test results; and (25) other factors detailed in our filings with the Securities and Exchange Commission, including, without limitation, those factors detailed in the Company's Annual Report on Form 10-K and its Form 10-Qs.
The statements made herein are independent statements of TASER International. The inclusion of any third parties does not represent an endorsement of any TASER International products or services by any such third parties.
This news release was distributed by PrimeNewswire, www.primenewswire.com
SOURCE: TASER International, Inc.
TASER International, Inc.
Steve Tuttle, Vice President of Communications
Media ONLY Hotline: (480) 444-4000